Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
E Green Global has commercialized the mass production of virus-free potato microtubers using proprietary in-vitro tissue culture methods. Their technology enables direct field planting, higher yields, and improved disease resistance compared to conventional seed potatoes. The company has established international partnerships and joint ventures to expand its reach, particularly in regions with high demand for quality seed potatoes such as the Middle East and Asia-Pacific. Recent clinical/commercial results include increased yield per hectare (from ~30 tons to over 46 tons) using their MCTs compared to imported seed potatoes.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on E Green Global.